Gonzalez-Cortes JH, Olvera-Barrios A, Perez-Salas JR, Trevino-Rodríguez HA, Trevino-Cavazos EE, Gonzalez-Cantu JE, Mohamed-Hamsho J

Language: English
References: 17
Page: 224-229
PDF size: 715.66 Kb.

ABSTRACT

Circumscribed choroidal hemangiomas (CCHs) are relatively rare. We report the response of a symptomatic CCH to photodynamic therapy (PDT). A 70-year-old male presented with blurred vision of the left eye (OS). Best-corrected visual acuity (BCVA) was 20/60 right eye and 20/160 OS. Biomicroscopy revealed bilateral cataracts. Diagnosis of CCH was made fundoscopically for OS and confirmed with optical coherence tomography (OCT). One session of PDT with individualized parameters was administered. After 2 months, anatomical improvement was evidenced with OCT and BCVA was 20/60. After cataract surgery, his BCVA was of 20/25 and remained stable. PDT showed excellent anatomic and visual results after a 2-year follow-up.

REFERENCES

1. Shields CL, Honavar SG, Shields JA, Cater J, Demirci H. Circumscribed choroidal hemangioma: clinical manifestations and factors predictive of visual outcome in 200 consecutive cases. Ophthalmology. 2001; 108:2237‑48.

2. Kim H, Wang A, Mititelu M. Case series of anti-vascular endothelial growth factor and photodynamic therapy in the treatment of circumscribed choroidal hemangiomas. J Vitro Retin Dis. 2017;1:133-7.

3. Boixadera A, García-Arumí J, Martínez-Castillo V, et al. Prospective clinical trial evaluating the efficacy of photodynamic therapy for symptomatic circumscribed choroidal hemangioma. Ophthalmology. 2009;116:100-50.

4. Zhang Y, Liu W, Fang Y, et al. Photodynamic therapy for symptomatic circumscribed macular choroidal hemangioma in Chinese patients. Am J Ophthalmol. 2010;150:710-50.

5. Shields JA, Shields CL, Materin MA, et al. Changing concepts in management of circumscribed choroidal hemangioma: the 2003 J. Howard stokes lecture, part 1. Ophthalmic Surg Lasers Imaging. 2004;35: 383-94.

6. Blasi MA, Tiberti AC, Scupola A, et al. Photodynamic therapy with verteporfin for symptomatic circumscribed choroidal hemangioma: five-year outcomes. Ophthalmology. 2010;117:1630-7.

7. Elizalde J, Vasquez L, Iyo F, Abengoechea S. Photodynamic therapy in the management of circumscribed choroidal hemangioma. Can J Ophthalmol. 2012;47(1):16-20.

8. Cerman E., Çekiç O. Clinical use of photodynamic therapy in ocular tumors. Surv Ophthalmol. 2015;60:557-74.

9. Agarwal A, Gass JD. Gass’ Atlas of Macular Diseases. 5th ed. Edinburgh: Elsevier Saunders; 2012.

10. Mashayekhi A, Shields CL. Circumscribed choroidal hemangioma. Curr Opin Ophthalmol. 2003;14:142-9.

11. Porrini G, Giovannini A, Amato G, Ioni A, Pantanetti M. Photodynamic therapy of circumscribed choroidal hemangioma. Ophthalmology. 2003;110 674‑80.

12. Schmidt-Erfurth UM, Michels S, Kusserow C, Jurklies B, Augustin AJ. Photodynamic therapy for symptomatic choroidal hemangioma: visual and anatomic results. Ophthalmology. 2002;109:2284-94.

13. Verbraak FD, Schlingemann RO, Keunen JE, de Smet MD. Longstanding symptomatic choroidal hemangioma managed with limited PDT as initial or salvage therapy. Graefes Arch Clin Exp Ophthalmol. 2003;241:891-8.

14. Singh AD, Kaiser PK, Sears JE, et al. Photodynamic therapy of circumscribed choroidal haemangioma. Br J Ophthalmol. 2004;88:1414-8.

15. Michels S, Michels R, Beckendorf A, Schmidt-Erfurth U. Photodynamic therapy for choroidal hemangioma. Long-term results. Ophthalmologe. 2004;101:569-75.

16. Jurklies B, Anastassiou G, Ortmans S, et al. Photodynamic therapy using verteporfin in circumscribed choroidal haemangioma. Br J Ophthalmol. 2003;87:84-9.

17. Schmidt-Erfurth U, Schlötzer-Schrehard U, Cursiefen C, et al. Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor. Invest Ophthalmol Vis Sci. 2003;44:4473-80.